Literature DB >> 20728059

Phenytoin-induced visual disturbances mimicking Delirium Tremens in a child.

Laura López Marín1, Juan José García-Peñas, Julian Lara Herguedas, Luis González Gutiérrez-Solana, Mariluz Ruiz-Falcó, Anna Duat Rodriguez, Verónica Cantarín Extremera.   

Abstract

Delirium Tremens is quite rare in children and it is usually caused by withdrawal or abstinence from alcohol, barbiturates and other major tranquilizers. The usual symptoms of Delirium Tremens include severe altered mental status with confusion, delusions, hallucinations, and severe agitation. Although psychosis is a recognized manifestation of Phenytoin toxicity, visual hallucinations are not. This study reports the case of a 4-year-old male with febrile seizures plus syndrome who developed acute complex visual hallucinations and psychomotor agitation early after therapy with intravenous Phenytoin was administered. These visual hallucinations mimicked those linked to Delirium Tremens and were not associated with an encephalopathy or other known neuropsychiatric side effects of this drug. Moreover, the hallucinations occurred while serum Phenytoin concentrations were below therapeutic range. We made an extensive investigation in order to exclude a non-convulsive Status Epilepticus, a Central Nervous System infection, a metabolic disorder, an underlying psychiatric disease and a possible drug toxicity. The temporal relationship between initiation of Phenytoin and onset of visual hallucinations and resolution of symptoms with withdrawal of Phenytoin suggests that the visual disturbances were probably due to that antiepileptic drug. Copyright (c) 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20728059     DOI: 10.1016/j.ejpn.2010.05.008

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  4 in total

1.  The novel sodium channel modulator GS-458967 (GS967) is an effective treatment in a mouse model of SCN8A encephalopathy.

Authors:  Erin M Baker; Christopher H Thompson; Nicole A Hawkins; Jacy L Wagnon; Eric R Wengert; Manoj K Patel; Alfred L George; Miriam H Meisler; Jennifer A Kearney
Journal:  Epilepsia       Date:  2018-05-21       Impact factor: 5.864

Review 2.  Impact of early life exposure to antiepileptic drugs on neurobehavioral outcomes based on laboratory animal and clinical research.

Authors:  Kevin G Bath; Helen E Scharfman
Journal:  Epilepsy Behav       Date:  2013-01-08       Impact factor: 2.937

3.  The outcome of agitation in poisoned patients in an Iranian tertiary care university hospital.

Authors:  Ali Mohammad Sabzghabaee; Ahmad Yaraghi; Elham Khalilidehkordi; Seyyed Mohammad Mahdy Mirhosseini; Elham Beheshtian; Nastaran Eizadi-Mood
Journal:  Neurol Res Int       Date:  2014-12-04

4.  Carbamazepine in Treatment of Visual Hallucinations: A Case of Chronic Hallucinatory Psychosis.

Authors:  Sayantanava Mitra; Sourav Khanra; Supriya Kumar Mondal; Anjana Rao Kavoor; Basudeb Das
Journal:  Indian J Psychol Med       Date:  2015 Oct-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.